| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Integrative Physiology |
From Advanced Cell Technology (R.L., M.D.W.), Worcester, Mass; Laboratory of Developmental Hematopoiesis (M.A.S.M., J.-H.S., J.H.), Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY; Laboratory for Genomic Reprogramming (T.W.) and Laboratory of Mammalian Molecular Embryology (A.C.F.P.), RIKEN Center for Developmental Biology, Kobe, Japan; and the Cardiovascular Research Institute (A.L., S.C., A.M., D.N., J.K., P.A.), Department of Medicine, New York Medical College, Valhalla, NY.
Correspondence to Piero Anversa, MD, Cardiovascular Research Institute, Department of Medicine, New York Medical College, Valhalla, NY. E-mail piero_anversa{at}nymc.edu
Nuclear transfer techniques have been proposed as a strategy for generating an unlimited supply of rejuvenated and histocompatible stem cells for the treatment of cardiac diseases. For this purpose, c-kitpositive fetal liver stem cells obtained from cloned embryos were injected in the border zone of infarcted mice to induce tissue reconstitution. Cloned embryos were derived from somatic cell fusion between nuclei of cultured LacZ-positive fibroblasts and enucleated oocytes of a different mouse strain. We report that regenerating myocardium replaced 38% of the scar at 1 month. The rebuilt tissue expressed LacZ and was composed of myocytes and vessels connected with the coronary circulation. Myocytes were functionally competent and expressed contractile proteins, desmin, connexin43, and N-cadherin. These structural characteristics indicated that the new myocytes were electrically and mechanically coupled. Similarly, the formed coronary arterioles and capillary structures contained blood and contributed, therefore, to tissue oxygenation. Cardiac replacement resulted in an improvement of ventricular hemodynamics and in a reduction of diastolic wall stress. These beneficial effects were obtained by stem cell transdifferentiation and commitment to the cardiac cell lineages. Myocardial growth was independent from fusion of the injected stem cells with preexisting partner cells. In conclusion, c-kitpositive stem cells derived by nuclear transfer cloning restore infarcted myocardium. Although problems currently plague nuclear transplantation, including the potential for epigenetic and imprinting abnormalities, stem cells derived from cloned embryos are sufficiently normal to repair damaged tissue in vivo. Importantly, the magnitude of myocardial regeneration obtained in this study is significantly superior to that achieved with adult bone marrow cells.
Key Words: fetal stem cells cardiac repair new coronary arterioles cardiomyocytes
This article has been cited by other articles:
![]() |
I. S. Jovin and F. J. Giordano Differentiation by association: is a cell's fate determined by the company it keeps? Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1503 - H1504. [Full Text] [PDF] |
||||
![]() |
P. Oettgen Cardiac Stem Cell Therapy: Need for Optimization of Efficacy and Safety Monitoring Circulation, July 25, 2006; 114(4): 353 - 358. [Full Text] [PDF] |
||||
![]() |
B. C. Heng and G. Q. Tong Mirror exchange of donor gametes should also accommodate scientific research. Hum. Reprod., April 1, 2006; 21(4): 1100 - 1100. [Full Text] [PDF] |
||||
![]() |
L. Armstrong, M. Lako, W. Dean, and M. Stojkovic Epigenetic Modification Is Central to Genome Reprogramming in Somatic Cell Nuclear Transfer Stem Cells, April 1, 2006; 24(4): 805 - 814. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Ayach, M. Yoshimitsu, F. Dawood, M. Sun, S. Arab, M. Chen, K. Higuchi, C. Siatskas, P. Lee, H. Lim, et al. Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction PNAS, February 14, 2006; 103(7): 2304 - 2309. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Eschenhagen and W. H. Zimmermann Engineering Myocardial Tissue Circ. Res., December 9, 2005; 97(12): 1220 - 1231. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ausoni, T. Zaglia, A. Dedja, R. Di Lisi, M. Seveso, E. Ancona, G. Thiene, E. Cozzi, and S. Schiaffino Host-derived circulating cells do not significantly contribute to cardiac regeneration in heterotopic rat heart transplants Cardiovasc Res, December 1, 2005; 68(3): 394 - 404. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Leri, J. Kajstura, and P. Anversa Cardiac Stem Cells and Mechanisms of Myocardial Regeneration Physiol Rev, October 1, 2005; 85(4): 1373 - 1416. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C Chachques, C. Salanson-Lajos, P. Lajos, A. Shafy, A. Alshamry, and A. Carpentier Cellular Cardiomyoplasty for Myocardial Regeneration Asian Cardiovasc Thorac Ann, September 1, 2005; 13(3): 287 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Wollert and H. Drexler Clinical Applications of Stem Cells for the Heart Circ. Res., February 4, 2005; 96(2): 151 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kajstura, M. Rota, B. Whang, S. Cascapera, T. Hosoda, C. Bearzi, D. Nurzynska, H. Kasahara, E. Zias, M. Bonafe, et al. Bone Marrow Cells Differentiate in Cardiac Cell Lineages After Infarction Independently of Cell Fusion Circ. Res., January 7, 2005; 96(1): 127 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Regula, M. J. Rzeszutek, D. Baetz, C. Seneviratne, and L. A. Kirshenbaum Therapeutic opportunities for cell cycle re-entry and cardiac regeneration Cardiovasc Res, December 1, 2004; 64(3): 395 - 401. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |